Gene Therapy for Rare Disorders is a uniquely focused conference that unites the leaders in the field to identify and discuss the critical factors that will influence genetic treatments most significantly in the near future.

Incorporating insights from 50+ industry-leading speakers, the meeting delves into the key regulatory, reimbursement, clinical and manufacturing hurdles that need to be overcome to realize the commercial potential of gene therapies.

Bringing together leading experts from innovative biotechs, large pharma, academia and key service provider companies, Gene Therapy for Rare Disorders will present a comprehensive insight into the cutting edge progress of gene therapies combatting rare disease.

Join 350+ of your colleagues to accelerate the progress of the next generation of gene therapies that show improved efficacy, enhanced safety and commercial viability.

To learn more and to register online, visit https://bit.ly/2ByuEe2